Blend Hold Time

21 CFR 211.111 requires that time limits be established for production operations 'when appropriate' to assure quality. For blends, the bridge between blender discharge and the next operation is the canonical case — the blend sits in an IBC or hopper, vibration during transport segregates fines, moisture exchanges with the environment, and lubricant coatings can continue to develop. The hold time validation establishes the longest interval over which the blend remains 'as released' from the blender.

• Typical validated holds — 24 hours, 48 hours, 7 days, depending on product.
• Validation includes uniformity, moisture, dissolution and microbial limits at the maximum hold.
• Hold conditions matter — sealed IBC vs open container, temperature, humidity.
• Lubricated blend hold is usually shorter than pre-blend hold.

• Seal IBC immediately on discharge — limits moisture exchange.
• Label with manufacture date/time, hold-expiry date/time, and storage conditions.
• Store in a defined hold area with controlled temperature and RH monitoring.
• Avoid vibration paths during hold — segregation accelerates with transport.
• Sample at end of hold (or at start of next operation) for BUE before compression.
• Track partial hold (some material withdrawn, rest re-held) — usually requires separate validation.

• No formal hold-time validation — operators 'know' it lasts a few days.
• Storing blends in open totes — moisture and contamination risk uncontrolled.
• Forgetting that lubricated blends are time-sensitive — the lubricant film keeps building.
• Treating IBC transport vibration as 'just transport' — segregation happens here.
• No end-of-hold uniformity check — degraded blends compressed silently.
• Re-holding partial blends without separate justification — repeated cycles compound risk.

• Solid-dose pharma — formal hold-time studies in PPQ; max hold becomes the SOP limit.
• Capsule fills — hold often shorter due to flow sensitivity of the fill machines.
• Effervescent — hold under strict low-humidity conditions to prevent reaction.
• Dietary supplements — 21 CFR 111.110 requires time limits on in-process holds when appropriate.
• Powder-fill biologics — shortest validated holds; cold-chain hold sometimes required.
• Veterinary medicated premix — hold studies tied to assay decay of the medicated active.